Skip to content

Effect of Adipose Tissue Derived Autologous Mesenchymal Stem Cell Concentrate on Bone Quality in Mandibular Fracture Healing.

Bone Quality Assessment Following Application of Adipose Tissue Derived Autologous Mesenchymal Stem Cell Concentrate in the Management of Mandibular Fractures. A Randomized Clinical Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07671183
Enrollment
20
Registered
2026-06-26
Start date
2026-07-01
Completion date
2027-02-01
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mandible Fracture

Keywords

bone quality, bone healing, mandibular fractures, mesenchymal stem cells, randomized clinical trial, fracture repair, bone regeneration, regenerative medicine

Brief summary

* The goal of study is to evaluate the effectiveness of adipose tissue derived-MSCs concentrate application in mandibular fractures. The main question it aims to answer is: Does intervention enhance bone quality, reduce complications and reduce bone regeneration time. * Researchers will compare the effectiveness of adipose tissue derived-MSCs concentrate application with ORIF to ORIF alone to see if MSCs improve healing in mandibular fractures. * Participants will: * Be managed either by adipose tissue derived-MSCs concentrate application with ORIF or ORIF alone. * Undergo CBCT immediately (T1) and 3 months (T4) postoperatively for bone density radiographic evaluation * Visit the clinic postoperatively at one week (T2), one month (T3), three months (T4) for clinical examination

Detailed description

* From oral and maxillofacial surgery outpatient clinic, Faculty of Dentistry, Cairo University. 20 patients will be included in this study, the patients will be randomly distributed into two groups each containing 10 patients, one group will be treated by application of adipose tissue derived autologous mesenchymal stem cell concentrate before and after fixation and the other group will be treated by fixation only without application of adipose tissue derived autologous mesenchymal stem cell concentrate. * All surgeries (for study and control groups) will be carried out with endotracheal intubation under general anaesthesia. * After scrubbing the surgical field with a povidone-iodine surgical scrub solution, the patients will be draped in sterile towels such that only the surgical site will be visible. * The fracture line will be exposed, followed by mobilization of the fracture, and removal of any soft tissue entrapped within the fracture line. Intermaxillary fixation (IMF) will be done and temporarily secured to provide proper occlusion that will serve as a guide for fracture reduction. * The reduction of the bone into appropriate anatomical occlusion will then be visually verified by confirming that the mandible is properly aligned. After that, the titanium plate is positioned and secured with titanium screws. * For the study group, abdominal lipo- suction will be carried out for the subsequent receive and gain of fat-derived stem cells following the microfragmentation of adipose tissue. This lipo-aspirate containing MSCs will be applied on fracture line before and following fixation.

Interventions

PROCEDUREAdipose tissue derived mesenchymal stem cells concentrate application in addition to the open reduction and internal fixation.

Abdominal fat liposuction will be carried out, microfragmentation of adipose tissue will be performed. Then the filtrate containing mesenchymal stem cells concentrate will be applied to the fracture line before and following fixation with titanium plates and screws .

PROCEDUREOpen reduction and internal fixation

Open reduction and internal fixation of fracture line with titanium plates and screws

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients with mandibular fracture. * Patients who are willing to participate in the study

Exclusion criteria

* Patients with systemic diseases influence bone healing * Patients with pathological fractures. * Infection located at the zone to be treated

Design outcomes

Primary

MeasureTime frameDescription
Bone density3 monthsAssessment of bone density at fracture healing site by CBCT

Secondary

MeasureTime frameDescription
Soft tissue dehiscence3 monthDetection of soft tissue dehiscence occurrence (Binary: Yes/ No)
Bleeding3 monthsDetection of bleeding occurrence (Binary: Yes/ No)
Infection3 monthsDetection of Infection occurrence (Binary: Yes/ No)
Malocclusion3 monthsDetection of malocclusion occurrence (Binary: Yes/ No)

Contacts

CONTACTMona Mahmoud Abdulhameed
monamabdulhameed@gmail.com00201001249384
STUDY_CHAIRMostafa Mohamed El-Gangehi, Professor

Faulty of Dentistry, Cairo University

STUDY_DIRECTORWalaa Kadry, Associate Professor

Faulty of Dentistry, Cairo University

STUDY_CHAIRSameh Mekhemer, Professor

Faulty of Dentistry, Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 30, 2026